Capella Biosciences is a virtual, discovery stage, start-up biopharma company developing novel medicines based on monoclonal antibodies (mAbs) for the treatment of oncology and autoimmune disease.

Capella Biosciences focuses on the employment of proprietary technologies to discover, develop, and commercialize medicines based on mAbs therapeutics independently, as well in collaboration with biotechnology and academic partners.